{
  "docId": "019de071-68ef-720e-a74a-8410f5ecfd30",
  "docSlug": "0e46fca7c64e4c4db862b8ec0b9f865c",
  "documentTitle": "GreenLight | SPAC Presentation Deck | 56 slides",
  "authorId": "greenlight",
  "authorName": "GreenLight Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 46,
  "pageCount": 56,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-68ef-720e-a74a-8410f5ecfd30/46",
  "deckHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30",
  "deckJsonHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30.json",
  "deckAnchorHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30#slide-46",
  "components": [
    {
      "bbox": {
        "h": 1,
        "w": 0.29,
        "x": 0.71,
        "y": 0
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97b5d525-6617-41cf-9239-9f4ab583def1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.6,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "list",
      "text": "1. Cutting edge, proven technology to democratize RNA, making it available to solve problems in the world’s most important markets: Agriculture, Food Production and Health\n2. Synthetic biology platform capable of producing RNA at scale, underscoring power of manufacturing at scale with highly competitive cost structure\n3. Blue ocean opportunity representing $130bn in TAM across 18 products, many without meaningful competition\n4. Multiple product development milestones expected in the next 2 years\n5. Best-in-class management team that has previously successfully scaled and commercialized biologics",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cece76e-beb2-4a76-9dce-aef86c00a63c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.07,
        "y": 0.08
      },
      "kind": "title",
      "text": "Why invest in us?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87624ba5-b4b5-4839-a53f-ff259305af00",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 46,
      "from": 46,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "30a41c53-d201-455c-a2a0-111f868eed55",
      "evidence": "Slide 46 presents the key takeaways.",
      "position": 2,
      "objective": "Why invest in GreenLight",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}